📊 Analyst Consensus & Targets
- Analyst Rating: Hold
- Price Target: $85.63636
- Sector: Healthcare – Medical Instruments & Supplies
💡 The Growth Thesis
Hold Consensus: Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. Analysts project a 8.1% potential upside. Currently trading at a Forward P/E of 12.455046.